AMPLY
To add a bio or update company history, please click update information.
News from AMPLY
AMPLY
11 Feb 2026
AMPLY Discovery secures strategic investment from Keeps Biomed for its AI-led oncology drug discovery solution
AMPLY Discovery applies AI to identify and validate new oncology drug targets. It combines computational analysis with laboratory testing to generate therapeutic programmes for partnering.
AMPLY
1 May 2025
AMPLY raises £1.3m seed led by Twin Path Ventures to accelerate drug discovery for aggressive cancers and superbugs
AMPLY builds an AI driven drug discovery platform that combines computational biology, sequencing and lab validation to develop new treatments for aggressive cancers and drug resistant infections.
AMPLY
- Life Sciences
- Belfast, United Kingdom
- amplydiscovery.com
- Update Information
More venture news
- 21 May 2026
ImperagenImperagen secures a £5m seed round led by PXN Ventures to accelerate the process of enzyme engineering
SeedLife Sciences - 12 May 2026
Infex TherapeuticInfex Therapeutics secures £4.3m in funding led by Jon Moulton for antimicrobial resistance treatments
EquityLife Sciences - 11 May 2026
Scarlet TherapeuticsScarlet Therapeutics raises a £3.2m seed round led by Eos Advisory to advance red blood cell treatments for diseases
SeedLife Sciences